Therapeutic effect of granulocyte colony stimulating factor on CCl4 induced chronic liver injury in mice
- VernacularTitle:粒细胞集落刺激因子对四氯化碳所致小鼠慢性肝损伤的治疗作用
- Author:
Junping WANG
;
Dianxing SUN
;
Bingshun LI
;
Fubiao KANG
;
Minran LI
;
Zhengrong GUO
;
Jiwen KANG
;
Weiyong LI
- Publication Type:Journal Article
- Keywords:
Liver cirrhosis;
Granulocyte colony stimulating factor;
Stem cells
- From:
Chinese Journal of Digestion
2008;28(4):242-245
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effects of recombinant human granulocyte colony stimulating factor(rhG-CSF)on CCl4 induced chronic liver injury.Methods Male BALB/C mice were randomly allocated into treatment and control groups.The mice model were established by injection with daily for 7 days,while the control mice were received the same volumes of saline.The mice were sacrificed to get weight,liver mass and spleen mass.The count of CD34+ cells and Thy-1+ cells were analyzed by flow cytometry and immunohistochemical staining,respectively.Results The ratio of liver/spleen was 15.94±1.20 and 10.52±0.66 on day 8 and 15 in treatment group,respectively,while those were 7.14±1.68 and 8.31±1.71 in control group,respectively(all P value<0.05).But there was no significant difference in body weight and liver mass between two groups(P>0.05)The concentration of album in treatment group was raised rapidly on day 15.The concentrations of alanine aminotransferase (ALT),aspartate aminotransferase(AST),hyaluronic acid(HA)and laminin(LN)on day 30 were significantly lower in treatment group compared to control group(P<0.05).There was significant difference in score of liver fibrosis on day 30 between two groups(treatment group:5.49±2.16,control:8.74±1.86,P<0.05).The number of CD34+ cell and Thy-1+ in treatment group(on day 8:9.54±2.24 and 5.10±1.25 and on day 15:8.18±1.93 and 7.53±1.39,respectively)were higher than those in control group(on day 8:5.40±0.99 and 3.25±0.75;on 15 days:4.46±0.77 and 3.35±0.86,all P value<0.05).Conclusion The rhG-CSF may improve the reparation of chronic liver injury,and may provide a novel method in treatment of liver fibrosis.